Amgen News
Most Popular Amgen Story
Analyst: Amgen to score big on Vectibix
Amgen sales could get a significant boost from two upcoming Vectibix trials. Such a boost, in fact, that a company selling its biggest competitor--Erbitux--saw itself downgraded by Merrill Lynch.... Read more...
Latest Headlines
- June 17, 2009
- April 14, 2009
- March 12, 2009
- March 2, 2009
- January 27, 2009
- December 24, 2008
- December 23, 2008
- December 18, 2008
- December 17, 2008
- December 16, 2008
- November 10, 2008
- November 7, 2008
- October 23, 2008
- October 3, 2008
- September 29, 2008
- September 19, 2008
- September 10, 2008
- August 28, 2008
- August 19, 2008
- August 6, 2008
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
